EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.